Angiotensin-converting enzyme blood test
Pro Research Analysisby 
Searched over 200M research papers
Angiotensin-Converting Enzyme (ACE) Blood Test: Overview and Clinical Relevance
The angiotensin-converting enzyme (ACE) blood test measures the activity or concentration of ACE in the blood. ACE is a key enzyme in the renin-angiotensin system, which regulates blood pressure and fluid balance. It is mainly found on the surface of vascular endothelial cells, especially in the lungs, but is also present in other tissues such as the brain, pancreas, and liver Bénéteau-Burnat1991Khurana2021.
Methods and Techniques for Measuring ACE in Blood
Enzyme Activity Assays
Most ACE blood tests determine enzyme activity using synthetic substrates, such as furylacryloyl-phenylalanyl-L-glycyl-L-glycine (FAPGG) or hippuryl-L-histidyl-L-leucine (HHL). These assays can be performed on serum or heparin-plasma samples and are often automated for clinical use. The tests are reliable, with analytical uncertainty typically between 2% and 5% depending on the ACE value in the sample Baudin2020Bénéteau-Burnat1991. Fluorimetric and radiochemical assays are also available, offering high sensitivity and specificity, but are less commonly used due to their complexity and equipment requirements Friedland1976Ryan1977Bénéteau-Burnat1991.
Advanced and Novel Approaches
Recent advances include high-performance liquid chromatography (HPLC) for direct quantification of ACE activity and bio-inspired plasmonic nanosensors that allow rapid, sensitive, and even naked-eye detection of ACE activity. These newer methods show promise for point-of-care diagnostics and drug screening Horiuchi1982Su2021.
ACE Phenotyping
A more comprehensive approach, known as ACE phenotyping, combines activity assays with immunoreactive protein quantification and analysis of ACE conformation using monoclonal antibodies. This method can detect the presence of ACE inhibitors, identify genetic mutations, and help establish normal reference values for different populations .
Clinical Applications of the ACE Blood Test
Diagnosis and Monitoring of Diseases
Elevated ACE levels in blood are most commonly associated with granulomatous diseases, particularly sarcoidosis, where the test is used for diagnosis, monitoring disease progression, and evaluating treatment response. Increased ACE can also be seen in other granulomatous conditions (e.g., silicosis, asbestosis, Gaucher’s disease, leprosy) and some non-granulomatous disorders (e.g., hyperthyroidism, cholestasis) Bénéteau-Burnat1991Studdy1983Khurana2021.
Conversely, decreased ACE activity may indicate vascular pathologies involving endothelial dysfunction, such as deep vein thrombosis or damage from chemotherapy and radiotherapy .
Blood Pressure Regulation and Cardiovascular Risk
ACE plays a central role in blood pressure regulation by converting angiotensin I to angiotensin II, a potent vasoconstrictor. Elevated ACE expression is linked to increased cardiovascular risk, and ACE inhibitors are widely used to treat hypertension and related conditions Samokhodskaya2021Khurana2021.
Genetic Factors and Reference Ranges
Genetic variations, particularly the insertion/deletion (I/D) polymorphism in the ACE gene, significantly affect serum ACE levels. Individuals with the D/D genotype have higher ACE levels than those with the I/I genotype. Genotype-specific reference values improve the sensitivity and specificity of ACE testing, especially in the follow-up of sarcoidosis .
Sample Handling and Test Reliability
ACE activity assays are robust, with samples stable at 4°C for at least a week. Freezing at -20°C is possible, but repeated freeze-thaw cycles should be avoided. The assays are linear over a wide range of ACE concentrations, and calibration ensures high fidelity and accuracy .
Limitations and Considerations
ACE levels can be influenced by age, sex, genetic background, and the use of ACE inhibitors. Therefore, interpretation of results should consider these factors, and there is a need for standardized methods and reference ranges across laboratories Baudin2020Biller2006Bénéteau-Burnat1991+1 MORE.
Conclusion
The ACE blood test is a valuable tool for diagnosing and monitoring several diseases, especially sarcoidosis and hypertension. Multiple reliable methods exist for measuring ACE activity, and newer technologies are enhancing test sensitivity and clinical utility. Genetic factors and patient-specific variables should be considered for accurate interpretation, and ongoing efforts aim to standardize testing and reference values for broader clinical application.
Sources and full results
Most relevant research papers on this topic